John M. Luk
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 12
- Liver physiology and pathology 11
- Hepatitis C virus research 11
- Cancer Research top 0.5%
- Cell Biology top 0.5%
- Molecular Biology top 1%
- Wnt/β-catenin signaling in development and cancer 22
- Cancer-related gene regulation 15
- Oncology top 2%
-
- Liver Disease Diagnosis and Treatment 20
- Hepatitis B Virus Studies 15
-
- Bacteriophages and microbial interactions 11
John M. Luk
182 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Hepatology 1.3k
- Cancer Research 1.8k
- Cell Biology 1.8k
- Molecular Biology 5.4k
- Oncology 1.5k
Countries citing papers authored by John M. Luk
This map shows the geographic impact of John M. Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Luk more than expected).
Fields of papers citing papers by John M. Luk
This network shows the impact of papers produced by John M. Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Luk. The network helps show where John M. Luk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John M. Luk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2020 | 20 | |
| 6 | 2014 | 150 | |
| 7 | 2013 | 198 | |
| 8 | 2011 | 26 | |
| 9 | 2010 | 57 | |
| 10 | 2009 | 14 | |
| 11 | A protein-based set of reference markers evenly expressed in liver tissues of healthy, cirrhosis and neoplastic states. | 2009 | 1 |
| 12 | 2008 | 27 | |
| 13 | 2006 | 11 | |
| 14 | 2006 | 358 | |
| 15 | 2004 | 10 | |
| 16 | 2001 | 20 | |
| 17 | 2000 | 29 | |
| 18 | 1996 | 6 | |
| 19 | 1992 | 3 | |
| 20 | 1989 | 10 |
About John M. Luk
John M. Luk is a scholar working on Hepatology, Cancer Research, Molecular Biology, Cell Biology and Endocrinology, having authored 187 papers that have together received 9.8k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (22 papers), Liver Disease Diagnosis and Treatment (20 papers), Hepatitis B Virus Studies (15 papers), Cancer-related gene regulation (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver physiology and pathology (11 papers), Bacteriophages and microbial interactions (11 papers) and Hepatitis C virus research (11 papers). The work is most often cited by research in Hepatology (1.3k citations), Cancer Research (1.8k citations), Cell Biology (1.8k citations), Molecular Biology (5.4k citations) and Oncology (1.5k citations). John M. Luk has collaborated with scholars based in Hong Kong, China and Singapore. Frequent co-authors include Angela M. Liu, Ronnie T. P. Poon, George Lau, Lars Zender, Kwong‐Fai Wong, Zhi Xu, Nikki P. Lee, Scott W. Lowe, Sheung Tat Fan and Irene Oi‐Lin Ng. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Clinical Microbiology, PLoS ONE, Cancer Research and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.